Plus Therapeutics (PSTV) Other Operating Expenses (2011 - 2023)

Plus Therapeutics (PSTV) has 12 years of Other Operating Expenses data on file, last reported at $2.7 million in Q4 2023.

• Other Operating Expenses for Q4 2023 came in at $2.7 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2024 was $2.7 million (up 136050.0% YoY), and the FY2021 annual result was -$66000.0, changed N/A from the prior year.
• Other Operating Expenses climbed to $2.7 million in Q4 2023 per PSTV's latest filing, from -$2000.0 in the prior quarter.
• Over five years, Other Operating Expenses peaked at $2.7 million in Q4 2023 and troughed at -$305000.0 in Q4 2019.
• A 4-year average of $381333.3 and a median of $94000.0 in 2019 frame the typical range for Other Operating Expenses.
• The sharpest annual moves came in 2019 and 2020: Other Operating Expenses tumbled 748.94% in 2019, then soared 705.15% in 2020.
• A 4-year view of Other Operating Expenses shows it stood at -$305000.0 in 2019, then surged by 356.07% to $781000.0 in 2020, then tumbled by 106.15% to -$48000.0 in 2021, then soared by 5764.58% to $2.7 million in 2023.
• Business Quant data shows PSTV's Other Operating Expenses at $2.7 million in Q4 2023, -$2000.0 in Q1 2023, and -$48000.0 in Q4 2021.